首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1615105

生物資訊學的全球市場規模:各技術，各用途，各地區，範圍及預測

Global Bioinformatics Market Size By Technology (Knowledge Management Tools, Bioinformatics Platforms), By Application (Metabolomics, Molecular Phylogenetics), By Geographic Scope And Forecast

出版日期: 2024年09月21日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

生物資訊市場規模及預測

2022年生物資訊市場規模為102.2億美元，預計2023年至2030年複合年增長率為16.29%，到2030年將達到397.4億美元。由於對複雜數據的需求不斷增加，測序成本下降對核酸和蛋白質測序的需求不斷增加，以及蛋白質組學和基因組學的應用不斷增加，全球生物資訊市場預計將很快出現顯著增長。此外，政府機構和私人公司的藥物發現和開發可能會在估計期間推動市場成長。本研究報告是一份全面評估全球生物資訊市場的市場研究報告。對關鍵細分市場、趨勢、推動因素、市場約束、競爭環境等重要因素進行了深入分析。

全球生物資訊市場的定義

生物資訊學是生物學和資訊科技的組合，它將生物數據與儲存、分發和分析資訊的技術相結合，支持包括生物醫學在內的多個科學研究領域。使用軟體工具進行資料庫形成、資料管理、資料倉儲、資料探勘等。挖掘此類數據會帶來技術發現，用於遺傳學和基因組研究。市場上有許多生物資訊學產品。它們的特點是蛋白質功能/分析工具、同源/相似性工具、序列分析工具和其他工具。

該領域涵蓋許多創新和專業領域，包括結構基因組學、高效基因組學、DNA 微陣列、比較基因組學和醫學資訊。因此，這些問題正在增加生物資訊學的全球市場佔有率。相反，對複雜解決方案和系統的需求不斷增加、醫療保健中機器學習和人工智慧的整合以及投資於生物資訊解決方案成長的軟體公司可以為生物資訊解決方案開發商提供利潤豐厚的市場機會。

全球生物資訊市場概況

全球生物資訊市場的成長很大程度上歸功於該領域數據和技術的進步，導致這些服務的標準不斷提高。許多國家目前正在投資人群測序計劃，以了解遺傳學與疾病之間的關聯。在全球範圍內，許多公共和商業機構正在穩步投資生物資訊學領域。尖端 NGS 技術的出現增加了對快速、準確的高效生物資訊工具的需求。

生物資訊學家是參與實驗探究的少數科學家。因此，獲得易於使用的工具對於利用生物資訊學平台至關重要。許多生物資訊學程式沒有用戶友好的介面，並且通常需要大量的電腦知識。未來幾年，新興國家在國際公司研發和投資方面的重要性預計將增加，這將為基因組學、代謝組學、精準醫學、藥物發現和其他市場的成長提供機會和亮點。

次世代定序 (NGS) 技術的快速發展正在產生大量的生物數據，隨著 NGS 的使用越來越頻繁，此數據量只會增加。在基因組分析中，還有很多材料需要研究，因此數據分析至關重要。因此，生物資訊分析後剩餘的數據非常有價值，可以再次使用。現有的解決方案未能令人滿意地解決生物資訊學中的數據管理課題。然而，缺乏熟練的人力資源、通用的數據格式以及缺乏廉價且用戶友好的工具預計將阻礙預測期內的市場發展。

Bioinformatics Market size was valued at USD 10.22 Billion in 2022 and is projected to reach USD 39.74 Billion by 2030, growing at a CAGR of 16.29% from 2023 to 2030. Due to an increase in the demand for combined data, an increase in the demand for nucleic acid and protein sequencing due to a drop in sequencing costs, and an increase in the applications of proteomics and genomics, the Global Bioinformatics Market is predicted to experience significant growth soon. In addition, drug discovery & development and enterprises from government & private organizations are probable to boost the market growth during the estimated period. The Global Bioinformatics Market report provides a holistic evaluation of the market. The research provides a thorough analysis of the market's key segments, trends, drivers, restraints, competitive environment, and other important elements.

Global Bioinformatics Market Definition

Bioinformatics is a grouping of biology and information technology, which links biological data with techniques for information storage, distribution, and analysis to support multiple areas of scientific research, with biomedicine. It uses software tools for database formation, data management, data warehousing, data mining, and others. Mining such data leads to technical discoveries, this is used in the study of genetics & genomes. Numerous bioinformatics implements are presented in the market. They are characterized as protein functional & analysis tools, homology & similarity tools, sequence analysis tools, and miscellaneous tools.

The field covers many innovative and specialized areas of life such as structural genomics, efficient genomics, DNA microarrays, comparative genomics, and medical information. Hence, these aforesaid issues increase the Global Bioinformatics Market share. Conversely, the increase in the need for combined solutions & systems, integration of machine learning & AI in healthcare, and software companies investing in the growth of bioinformatics solutions are predictable to offer remunerative market opportunities to bioinformatics solutions developers.

Global Bioinformatics Market Overview

The growth of the worldwide Bioinformatics Market is largely attributable to data and technological advancements in the field, which have improved the standard of these services. To understand the connection between genetics and diseases, many nations are now investing in their national population sequencing initiatives. Globally, numerous public and commercial institutions are steadily making investments in the field of bioinformatics. With the advent of cutting-edge NGS technology, there is an increasing demand for efficient bioinformatics tools that are speedy and accurate.

Bioinformaticians make up a small majority of the scientists involved in the experimental inquiry. As a result, having access to user-friendly tools is essential for using bioinformatics platforms. Because many bioinformatics programs lack an appropriate user-friendly interface, they frequently require significant computer knowledge. In the upcoming years, it is anticipated that the rising significance of these emerging economies in terms of R&D and investments from international companies will offer a positive outlook-as well as opportunities-for the growth of genomics, metabolomics, precision medicine, drug discovery, and other markets.

A significant amount of biological data has been generated by the quick development of next-generation sequencing (NGS) technology, and this data volume is growing as NGS is used more frequently. Data analysis is essential because there is still a ton of material to be investigated in genomic analysis. As a result, the data that is left over after bioinformatics analysis is extremely valuable and can be used again. The challenges of data management in bioinformatics are not sufficiently addressed by the available solutions. However, a lack of skilled personnel, common data formats, and the absence of user-friendly tools at cheaper prices are projected to hamper the market development during the forecast period.

Global Bioinformatics Market: Segmentation Analysis

The Global Bioinformatics Market is segmented on the basis of Technology, Application, and Geography.

Bioinformatics Market, By Technology

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

Based on Technology, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services. The bioinformatics platforms sector was the main income and is anticipated to endure this trend during the projected period, owing to a rise in platform applications and the need for better tools in drug development. An increase in platform application is credited to a surge in need from the life science firm for the identification and alteration of structures. This, in chance, would help in the drug scheming process and assessment of their therapeutic effects. Furthermore, competence and safety in drug development and discovery lead to an upsurge in the need for better tools in drug development. Thus, is expected to drive the Bioinformatics Market size in the upcoming.

Bioinformatics Market, By Application

Metabolomics
Molecular phylogenetics
Transcriptomics
Proteomics
Chemoinformatics & drug design
Genomics
Others

Based on Application, the market is segmented into Metabolomics, Molecular phylogenetics, Transcriptomics, Proteomics, Chemoinformatics & drug design, Genomics, and Others. The transcriptomics segment is predicted to exhibit the highest growth during the forecast period, owing to an increase in favor of companion diagnostics and personalized medicines. Moreover, novel gene sequencing, uninterrupted detection of biomarkers, and universal acceptance of transcriptomics technology are expected to drive the Bioinformatics Market growth.

Bioinformatics Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Regional Analysis, The Global Bioinformatics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America dominated the market, accounting for the highest share, and is anticipated to continue this trend throughout the forecast period. This is recognized as to surge in the adoption of advanced technology and growth in demand for better bioinformatics tools, which are required in the drug discovery and development process. The market in LAMEA is expected to grow at the highest revenue during the forecast period, owing to advancements in the field of genomics and proteomics, producing a massive volume of statistics, which is to be understood and accomplished.

Key Players

The "Global Bioinformatics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Agilent Technologies, Inc., Biomax Informatics AG, DNAnexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina Inc., Perkinelmer Inc., Qiagen N.V., Seven Bridges Genomics Inc., Thermo Fisher Scientific, Inc.
The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In September 2021, Agilent Technologies Inc. has announced an agreement of a global distribution with Visiopharm, which will allow Agilent to co-market Visiopharm's portfolio of CE-IVD obvious AI-driven precision pathology software in addition to its portfolio of automated pathology staining solutions. This partnership, which initially focuses on Europe, represents Agilent's entry into the growing digital pathology sector and improves the relationship between the two businesses by enhancing the possibility of their future cooperation.
In April 2022, Logica, a drug resolution driven by artificial intelligence (AI) that directly turns clients' biological insights into improved preclinical assets, was introduced by Charles River and Valo Health. Logica makes use of Charles River's leading preclinical experience and Valo's AI-powered Opal Computational Platform to provide clients with transformed drug development with a single integrated contribution that effortlessly converts scores to candidate submissions.
In July 2021, the debut of nRavel, a unique AI discovery platform for oncology and precision medicine, was announced by Indivumed GmbH. The platform integrates IndivuType's rich multi-omics data with a comprehensive set of advanced analytics capabilities, powerful automated machine learning algorithms, and attractive disease models.

1 INTRODUCTION OF GLOBAL BIOINFORMATICS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BIOINFORMATICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL BIOINFORMATICS MARKET, BY TECHNOLOGY

5.1 Overview
5.2 Knowledge Management Tools
5.3 Bioinformatics Platforms
5.4 Bioinformatics Services

6 GLOBAL BIOINFORMATICS MARKET, BY APPLICATION

6.1 Overview
6.2 Metabolomics
6.3 Molecular Phylogenetics
6.4 Transcriptomics
6.5 Proteomics
6.6 Chemoinformatic
6.7 Drug Design
6.8 Genomics
6.9 Others

7 GLOBAL BIOINFORMATICS MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL BIOINFORMATICS MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Agilent Technologies, Inc.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Biomax Informatics AG
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 DNAnexus, Inc.
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Genedata AG
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Intrexon Bioinformatics Germany GmbH
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Illumina Inc.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Perkinelmer Inc.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Qiagen N.V.
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Seven Bridges Genomics Inc.
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Thermo Fisher Scientific, Inc.
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments